Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-03-01 to 2025-03-03
Current total value of award: $1440.48
Description: 4567432926!QUILLIVANT XR 25 MG/5 ML SUSP 150ML